Skip to main content

Contract Research Organization (CRO`s) Services Market 2030

The global Contract Research Organization (CRO) Services Market is expected to reach USD 91.2 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.2% from 2021 to 2030. The growth of the market is attributed to the increasing demand for cost-effective drug development services, the rising prevalence of chronic diseases, and the growing number of clinical trials.

The increasing demand for personalized medicine and the growing focus on drug safety and efficacy are also expected to drive the market growth. The increasing number of mergers and acquisitions among CRO`s is also expected to contribute to the growth of the market. Furthermore, the increasing adoption of advanced technologies such as artificial intelligence (AI) and machine learning (ML) is expected to create lucrative opportunities for the market.

Contract Research Organization (CRO`s) Services Market 2030

The market is segmented based on service type, therapeutic area, end-user, and region. By service type, the market is divided into preclinical services, clinical trial services, and post-approval services. The clinical trial services segment is expected to dominate the market during the forecast period due to the increasing number of clinical trials and the rising demand for cost-effective drug development services.

By therapeutic area, the market is divided into oncology, neurology, cardiovascular diseases, infectious diseases, and others. The oncology segment is expected to dominate the market during the forecast period due to the increasing prevalence of cancer and the rising demand for personalized medicine.

By end-user, the market is divided into pharmaceutical and biotechnology companies, medical device companies, and academic and research institutes. The pharmaceutical and biotechnology companies segment is expected to dominate the market during the forecast period due to the increasing number of clinical trials and the rising demand for cost-effective drug development services.

Regionally, the market is divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the market during the forecast period due to the presence of a large number of Contract Research Organization in the region and the increasing demand for personalized medicine.

Contract Research Organization (CRO`s) Services Market 2030

The key players in the market include Parexel International Corporation, IQVIA Holdings Inc., Covance Inc., Syneos Health Inc., Charles River Laboratories International Inc., ICON plc, PRA Health Sciences Inc., Wuxi AppTec Co., Ltd., Pharmaceutical Product Development LLC (PPD), VIal CRO and Clinipace Worldwide. These players are focusing on strategies such as mergers and acquisitions, collaborations, and product launches to gain a competitive edge in the market.

Labels:
Location: United States

Comments

Post a Comment

Popular posts from this blog

Clinical Research Organization Services Market by 2018-2033

Clinical research organization services are the services provided by the clinical research organizations (CROs) to the pharmaceutical, biotechnology, and medical device companies. Clinical research organization services include clinical trial management, clinical data management, biostatistics, regulatory affairs, and other services. The global clinical research organization services market is expected to reach USD 59.2 billion by 2033 from USD 33.2 billion in 2018, at a CAGR of 6.7%. The growth of the clinical research organization services market is mainly driven by the increasing number of clinical trials, rising demand for outsourcing of clinical trials, and increasing focus on the development of biologics and biosimilars. However, the high cost of clinical trials and stringent regulatory requirements are expected to restrain the growth of this market during the forecast period. The clinical trial management segment is expected to account for the largest share of the clinical rese...
Post a Comment
Read more

Preclinical Contract Research Organization (CRO) Market by Manufacture, Sales, Revenue, Forecast by Regions 2023-2029

The Preclinical Contract Research Organization (CRO) Market report provides a comprehensive overview of the market, including market dynamics, segmentation, and regional analysis. The Preclinical Contract Research Organization (CRO) Market report report also provides an overview of the competitive landscape and the key strategies adopted by market players to gain a competitive edge in the market.  The Preclinical Contract Research Organization - CRO`s Market report also provides an overview of the competitive landscape and the key strategies adopted by market players to gain a competitive edge in the market. The report provides an in-depth analysis of the Preclinical Contract Research Organization (CRO) market, including market size, growth drivers, market trends, and competitive landscape. The report also provides an overview of the key players in the market and their strategies for gaining a competitive edge in the market. The report also provides an overview of the key trends ...
Post a Comment
Read more

Exploring Huge Demand of Oncology CRO Market 2023 - 2033

The Oncology CRO market is expected to grow significantly over the forecast period due to the increasing prevalence of cancer, rising demand for personalized medicine, and the growing need for cost-effective drug development. The increasing number of clinical trials in Oncology and the growing demand for outsourcing services are also expected to drive the growth of the market. The Oncology CRO‘s market is segmented based on type, end-user, and region. By type, the market is divided into preclinical, clinical, and post-marketing services. Preclinical services are expected to hold the largest share of the market due to the increasing demand for preclinical studies in oncology. Clinical services are expected to witness the highest growth rate due to the increasing number of clinical trials in oncology. By end-user, the market is divided into pharmaceutical and biotechnology companies, academic and research institutes, and contract research organizations. Pharmaceutical and biotechnology...
Post a Comment
Read more